| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |